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Abstract
Background: Sanfilippo syndrome type B (MPS III B) is caused by a deficiency of a-N-acetylglucosaminidase enzyme, leading
to accumulation of heparan sulfate within lysosomes and eventual progressive cerebral and systemic multiple organ
abnormalities. However, little is known about the competence of the blood-brain barrier (BBB) in MPS III B. BBB dysfunction
in this devastating disorder could contribute to neuropathological disease manifestations.
Methodology/Principal Findings: In the present study, we investigated structural (electron microscope) and functional
(vascular leakage) integrity of the BBB in a mouse model of MPS III B at different stages of disease, focusing on brain
structures known to experience neuropathological changes. Major findings of our study were: (1) endothelial cell damage in
capillary ultrastructure, compromising the BBB and resulting in vascular leakage, (2) formation of numerous large vacuoles
in endothelial cells and perivascular cells (pericytes and perivascular macrophages) in the large majority of vessels, (3)
edematous space around microvessels, (4) microaneurysm adjacent to a ruptured endothelium, (6) Evans Blue and albumin
microvascular leakage in various brain structures, (7) GM3 ganglioside accumulation in endothelium of the brain
microvasculature.
Conclusions/Significance: These new findings of BBB structural and function impairment in MPS III B mice even at early
disease stage may have implications for disease pathogenesis and should be considered in current and future development
of treatments for MPS III B.
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Introduction
Mucopolysaccharidoses (MPS) are inherited lysosomal storage
disorders caused by malfunctioning of particular lysosomal
enzymes. The resulting accumulation of undegraded glycosami-
noglycans (GAGs) within lysosomes leads to progressive cellular
damage affecting normal organ and system function. Sanfilippo
syndrome type B (MPS III B) is one of four MPS III (Sanfilippo
syndrome) subtypes and is characterized by a deficiency of a-N-
acetylglucosaminidase (Naglu), the enzyme responsible for degra-
dation of heparan sulfate (HS). Accumulation of HS in lysosomes
leads to progressive cerebral and systemic multiple organ
abnormalities. Clinical symptoms such as hyperactivity and
aggressive behavior appear between two and six years of age
and are followed by hearing or vision defects, pathological skeletal
changes, and mental retardation [1,2]. MPS III patients
experience pathological changes in the brain characterized by
varying degrees of cortical atrophy and ventricular enlargement
[3,4]. In some patients, callosal atrophy and cerebellar changes
were noted along with morphological abnormalities in Purkinje
cells [5]. Death usually occurs between 11 and 20 years of age.
Treatment of patients with MPS III B is mainly supportive.
The disorder is caused by mutations in the Naglu gene located on
chromosome 17q21, a gene encoding a lysosomal enzyme needed for
degradation of heparan sulfate [6]. A knockout mouse model of MPS
III B, presenting biochemical abnormalities similar to the human
disease, has been created by disrupting this gene [7]. The Naglu
deficient mice show progressive deterioration of motor, vision, and
hearing functions [8]. Histopathological changes such as vacuoliza-
tion, observed in multiple mouse organ systems as early as the first
month of age, become more prominent over time. Initial symptoms
present at about 6 months and mice survive until 8 to 12 months of
age [7]. Neurons are affected in various parts of the brain such as the
olfactory bulb, cortex, thalamus, amygdala, midbrain, pons, medulla,
and cerebellum, leading to neuropathological alterations. Accumu-
lation of gangliosides GM2 and GM3, secondary storage products,
and formation of large cytoplasmic inclusions have been reported in
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reactive astrocytes in the cerebral cortex and hippocampus of 3
month and 6 month old Naglu mice [11], activated microglia [12],
and the presence of pro-inflammatory cytokine IFN-c in the mouse
cerebral cortex at 1 month of age [12] indicate inflammatory
processes in the brains of mice modeling MPS III B.
Thus, MPS III B presents a complexity of pathological factors.
However, little is known about the condition of the blood-brain
barrier (BBB) in MPS III B. BBB dysfunction in this disorder could
contribute to neuropathological disease manifestations by acceler-
ating cell death. The primary function of the BBB is controlling
cerebral homeostasis by selective transport of molecules and cells
from the systemic compartment [13–15]. The BBB is composed of
the unique structural elements of the microvasculature –
endothelial cells of brain capillaries, epithelial cells of the choroids
plexus, astrocyte end-feet, and pericytes. Endothelial cells are
connected via adherens and tight junctions, forming a diffusion
barrier. Functional integrity of all BBB elements is critical for
protection of the CNS from harmful blood substances. Substances
with molecular weights greater than ,400 Da are too large to
cross the BBB by free diffusion. Compromised BBB integrity has
been demonstrated in some lysosomal storage diseases (reviewed in
[16]). Extravasation of Evans Blue and endogenous IgG was found
in mouse models of GM2 (Sandhoff disease) and GM1
gangliosidoses [17]. Interestingly, IgG leaky vessels were more
pronounced in the stratum radiatum of the hippocampus, medial
thalamus, and the inferior colliculus in Sandhoff mice at late stage
of disease. In MPS II and MPS III B patients, dilatation of the
perivascular space around the brain capillaries was noted in the
cerebral white matter [18]. However, no data exist about
structural and functional BBB state in MPS III B, specifically in
various brain structures and at different disease stages. Determin-
ing BBB condition in MPS III B is crucial to understanding
additional mechanisms of disease pathogenesis and to developing
pharmacological and/or cellular treatments.
The aim of this study was to determine structural and functional
integrity of BBB in a mouse model of Sanfilippo type B at different
stages of disease. The primary focus was analyzing BBB
competence in various brain structures known to experience
neuropathological changes.
Results
Microvascular ultrastructure in various brain structures of
Naglu mutant mice
Brain structures of control mice (10–12 months old) were
characterized by normal appearance of neurons, myelinated
axons, capillaries, and surrounding astrocytes (Figures 1–4, A,
B). All blood vessels were surrounded by healthy neuroglia cell
processes. Erythrocytes were observed in the lumen of the
capillaries. Cell organelles were well preserved and mitochondria
showed a normal pattern of cristae. Capillaries consisted of a single
layer of endothelial cells surrounded by a layer of basement
membrane, forming an intact BBB.
Three months old Naglu mice (early symptomatic), displayed
ultrastructural abnormalities in capillary endothelia of the cortex
(Figure 1, C, D), hippocampus (Figure 2, C, D), striatum (Figure 3,
C, D), and cerebellum (Figure 3C). Endothelial cells (ECs) showed
endoplasmic reticulum swelling and numerous large vacuoles in cell
cytoplasm. Unusually large lysosomes containing dark inclusions
were detected in cytoplasm of endothelial cells. (Figure 1D). Blood
vessels were surrounded by either degenerating astrocytes or
edematous space. Large vacuoles were noted adjacent to capillaries.
Neurons with numerous cytoplasmic vacuoles were detected.
Microvilli and their fragments were observed floating free in the
capillary lumen. Highly vacuolated perivascular macrophages,
containing storage products, were found in contact with microves-
sels in the cortex and hippocampus (Figure 2C). Pericytes
surrounding capillaries also contained numerous large vacuoles in
theircytoplasmcausingcellswelling inall examined brainstructures
(Figure 1, C, D), (Figure 2C), (Figure 3, C, D), (Figure 4C). Platelets
attracted to the region of endothelial cell damage were found in the
hippocampus (Figure 2C).
In 6 months old Naglu mice (late symptomatic), severe vascular
damage was observed in both capillaries and large vessels from all
analyzed regions of the brain. In addition to vascular abnormalities
described above in 3 months old Naglu mice, further swelling and
vacuolation of the capillary endothelium was noted. Vacuoles
containinglight and dark material causing swollen ECand pericytes
were found in the cortex (Figure 1E), hippocampus (Figure 2F),
striatum (Figure 3E), and cerebellum (Figure 4, D, E). Enlarged
pericyte nuclei in the hippocampus were observed (Figure 2F). A
cerebral (Figure 4E) capillary was surrounded by two pericytes
containing large vacuoles which displaced and destroyed cell
organelles. Vacuolated perivascular macrophages were also seen
in the cortex (Figure 1F) and cerebellum (Figure 4D). In some
microvessels, a single layer of endothelium was observed, while
others were surrounded by multiple layers of endothelial cells and
basement membrane indicating a reparative process (Figure 3F).
Perivascular space could be observed around the capillaries. A
microaneurysm was visible in the hippocampus, adjacent to a
ruptured endothelium. In the microaneurysm, an erythrocyte could
be seen trapped under the basement membrane, portending the
aneurysm’s imminent rupture (Figure 2E). Interestingly, myelinated
axons and dendrites filling the neuropil surrounding capillaries were
not destroyed in all examined brain areas of Naglu mice at early or
late stage of disease. Note, all described ultrastructural BBB
abnormalities were similar in both mutant male and females.
Detection of Evans blue and albumin leakage in various
brain structures of Naglu mutant mice
The functional competence of the BBB in Naglu mice at different
stages of disease was determined by examining vascular leakage of
EB, 961 Da, and albumin, 68 kD. In control wild type mice at 3, 6
or 10-12 months of age, EB (Figure 5, A–C) and albumin (Figure 6,
A–C) were clearly detected within the blood vessels of the brain.
Vascular leakage of EB and albumin was observed in early (3
months of age) (Figures 5 and 6, D–F) and late symptomatic Naglu
mice (6 months of age) (Figures 5 and 6, G, H, I) in various brain
structures. Significant EB and albumin diffusion into the
parenchyma of the brain from multiple blood vessels was detected
in both male and female end stage Naglu mice (10–12 months of
age) (Figures 5 and 6, J–L). Although the entire sectioned brain
was analyzed for vascular leakage, the majority of blood vessel
leakage was detected in the cerebellar lobules (6–9Cb), cerebral
cortex (M2), hippocampus (CA1, CA2), and midbrain of mutant
mice at all disease stages (Table 1). Although both EB and albumin
extravasation abnormalities were commonly found in the same
microvessels (Figures 5 and 6, E, K, L), some capillaries showed
only EB leakage. Interestingly, neither EB nor albumin leakage
was indicated in the olfactory bulb. Thus, vascular leakage of EB
and albumin was detected in Naglu mice not only at late stage of
disease but also concurrent with early disease symptoms.
Immunohistochemical staining for GM3 ganglioside in
brains of Naglu mice
Significant GM3 ganglioside accumulation was seen in
neurons and glial cells in both male and female Naglu mice.
BBB in MPS III B
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lium of blood vessels (Figure 7, A–C) in control wild type mice.
In early symptomatic (3 months old) Naglu mice, some
endothelial cells stained positive for GM3 (Figure 7, D–F).
More GM3 accumulation was seen in the endothelia of
numerous brain blood vessels at late (6 months of age) and
end stages of disease (10 months of age) in the cerebral cortex
(Figure 7, G, J), hippocampus (Figure 7, H, K), and cerebellum
(Figure 7, I, L).
Discussion
In the present study, we investigated the structural and
functional integrity of the blood-brain barrier in a mouse model
of Sanfilippo type B (MPS III B) at different stages of disease. The
primary focus was determining BBB competence in brain
structures known to experience neuropathological changes such
as the cerebral cortex, hippocampus, striatum, and cerebellum.
Major findings of our study were: (1) capillary ultrastructure
Figure 1. Electron microscope examination of the cerebral cortex of Naglu mutant mice. (A) Representative area of C57 BL/6J control
mouse cerebral cortex characterized by normal ultrastructural appearance of neurons, myelinated axons, and capillaries. (B) Capillary at high
magnification from the cerebral cortex of control mouse consists of a single layer of endothelial cells surrounded by a layer of basement membrane,
forming an intact BBB. Erythrocytes can be observed in the lumen of the capillary. Organelles in all cells were well preserved. (C) In the cortex of Naglu
mutant mouse at 3 months of age (early symptomatic), endothelial cells and pericyte show formation of numerous large vacuoles in their cytoplasm.
Microvilli and their fragments can be observed floating free in the capillary lumen. (D) Highly vacuolated pericyte was found in contact with
microvessel basement membrane in 3 months old mutant mice. Edematous space is observed around vessels. (E) In late symptomatic (6 months of
age) mutant mouse, large vacuoles containing light and dark material cause swelling of a pericyte, displacing organelles. (F) Longitudinal section of
capillary showing large perivascular macrophage with numerous vacuoles in its cytoplasm near the blood vessel in the cortex of a 6 month old Naglu
mouse. Numerous vacuoles were found in cells surrounding the capillary. EC - endothelial cell, BM - basement membrane, E – erythrocyte, m –
mitochondrion, A – axon, P – pericyte, PM – perivascular macrophage, Nu – nucleus, V – vacuole, L – lysosome, asterisks - microvilli.
Magnifications: (A), (D), (F): 7,100x; (B), (C): 14,000x; (E): 4,400x.
doi:10.1371/journal.pone.0016601.g001
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which compromised the BBB, resulting in vascular leakage, (2)
endothelial cells showed endoplasmic reticulum swelling and
formation of numerous large cytoplasmic vacuoles, degeneration
of cytoplasmic organelles, abnormal microvilli formation, and
shedding of fragments of cell membrane and microvilli, (3)
edematous space was detected surrounding microvessels, (4)
pericyte degeneration was observed in the large majority of
damaged vessels, (5) highly vacuolated perivascular macrophages
were found in contact with microvessels, (6) a microaneurysm was
visible adjacent to a ruptured endothelium, (7) EB and albumin
microvascular leakage was clearly indicated in multiple brain
structures, (8) GM3 ganglioside accumulation was determined in
brain microvasculature endothelium. Structural and functional
impairment of the BBB in the MPS III B mouse model is a novel
finding. This new discovery of microvascular damage in mice even
at early disease stage may have implications for disease
pathogenesis.
The BBB structure and function have been detailed in
numerous reviews [13–15,21] emphasizing the BBB’s neuropro-
tective role in maintaining a stable fluid environment in the brain.
This unique microvascular barrier in the brain prevents the
Figure 2. Electron microscope examination of the hippocampus of Naglu mutant mice. (A), (B) Hippocampal area of C57 BL/6J control
mouse shows typical normal ultrastructure of neurons and all capillary components. (C) Vacuolated endothelial cells and pericytes can be observed in
3 months old Naglu mouse. A highly vacuolated perivascular macrophage was also noted. Platelets attracted to a region of endothelial cell damage
are visible. (D) Perivascular space can be observed around the capillaries in the hippocampus of an early symptomatic mouse at 3 months of age. (E)
In Naglu mouse at 6 months of age, a microaneurysm is visible in the hippocampus, adjacent to a ruptured endothelium. In the microaneurysm, an
erythrocyte can be seen trapped under the basement membrane, portending imminent aneurysm rupture. (F) Under high magnification, distended
nucleus of pericyte with large vacuoles can be observed in late symptomatic mutant mouse. EC - endothelial cell, BM - basement membrane, E –
erythrocyte, m – mitochondrion, A – axon, N – neuron, P – pericyte, PM – perivascular macrophage, Nu – nucleus, V – vacuole, Ma –
microaneurysm, pl – platelets, asterisks - microvilli, . - extracellular edematous space. Magnifications: (A), (B), (D), (E): 7,100x; (C): 3,500x; (F):
8,900x.
doi:10.1371/journal.pone.0016601.g002
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transport systems allow influx of various required substances and
efflux of cell products to maintain CNS homeostasis [21,22].
However, BBB dysfunction or damage to any structural BBB
elements would likely unbalance the fragile CNS equilibrium.
Although compromised BBB integrity has been shown in some
lysosomal storage diseases (reviewed in [16]), this is the first report
demonstrating microvascular endothelial cell damage in brains of
mice modeling MPS III B. The numerous vacuoles detected in
endothelial cell cytoplasm, even in early symptomatic mice, may
degrade cell function leading to BBB impairment. This barrier
damage was confirmed by vascular leakage of Evans Blue and
albumin resulting from endothelium damage in MPS III B mice,
similar to extravasation of Evans Blue and endogenous IgG
findings in mouse models of Sandhoff disease and GM1
gangliosidosis [17]. Jeyakumar et al. [17] also revealed that
Figure 3. Electron microscope examination of the striatum of Naglu mutant mice. (A) Structural integrity of capillaries in the striatum was
normal in C57 BL/6J control mice. (B) A single layer of endothelial cells surrounded by a layer of basement membrane in control mouse seen at high
magnification. (C), (D) Edematous space and large vacuoles are indicated around vessels. Vacuolated pericytes can be seen in the striatum of early
symptomatic Naglu mice. (E) Large vacuoles were found in endothelial cells and pericytes of late symptomatic animals. (F) A high magnification
image of a capillary from the striatum of a 6 month old mutant mouse showing an endothelial cell with endoplasmic reticulum swelling and
formation of a large vacuole in its cytoplasm. Edematous space has appeared around the capillary. Multiple layers of endothelial cells and basement
membrane can be observed here, indicating a reparative process taking place. The luminal endothelial cells are damaged.E C- endothelial cell, BM -
basement membrane, E – erythrocyte, m – mitochondrion, A – axon, P – pericyte, PM – perivascular macrophage, Nu – nucleus, V – vacuole, + -
swollen endoplasmic reticulum, asterisks - microvilli, . - extracellular edematous space. Magnifications: (A), (C): 7,100x; (B), (E): 14,000x; (D): 8,900x;
(F): 28,000x.
doi:10.1371/journal.pone.0016601.g003
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branous cytoplasmic bodies were indicated in ultrastructure of
some brain areas of these mice. Capillary endothelial cell
dysfunction, potentially allowing harmful blood-borne solutes
including neurotoxins to enter the CNS, may accelerate
neuropathological changes in MPS III B. Alternatively, damaged
endothelial cells may alter specific mechanisms for transport of
various solutes across the BBB. In this scenario, CNS neural cells
might suffer the dual effects of reduced nutrition and increased
metabolite levels, impairing CNS function.
Additional to endothelial cell damage, pericyte degeneration
was observed in the majority of capillaries from examined brain
structures in early and late symptomatic MPS III B mice. Large
vacuoles displacing and destroying cell organelles were seen in
most pericytes surrounding capillaries. Pericytes are believed to be
cells of mesodermal origin derived from mesenchymal precursor
cells and during angiogenesis remain enclosed within the basal
lamina. A number of reviews have revealed the important role of
pericytes in maintaining BBB integrity [23–26]. Due to their
location and properties, pericytes have been proposed as
contractile cells regulating blood flow and vascular tone.
Imperative pericyte function includes vessel permeability regula-
tion, control of microvascular remodeling and new capillary
growth, immunologic defense, matrix protein synthesis, and
interaction with endothelial and other cells providing vessel
stabilization. Interactions between pericytes and endothelial cells,
via secreted soluble factors such as platelet-derived growth factor
and transforming growth factor beta 1, are vital to the growth and
Figure 4. Electron microscope examination of the cerebellum of Naglu mutant mice. (A), (B) Similar to ultrastructure of microvessels in the
cerebral cortex, hippocampus, and striatum, the intact BBB in the cerebellum of a C57 BL/6J control mouse consists of an endothelial cell and a single
layer of basement membrane. (C) Edematous space around vessel as well as vacuolated pericyte is found in the cerebellum of 3 months old mutant
mouse. Vacuoles are also seen in the cytoplasm of neuron located near vessel. (D) In 6 months old Naglu mice, two highly vacuolated perivascular
macrophages surround a microvessel. Edematous space around vessels is in contact with astrocytic end-feet. (E) Pericytes, which contain large
vacuoles displacing and destroying cell organelles, can be seen under the capillary basement membrane in mouse at the same stage of disease. Large
vacuoles are also visible outside vessel. EC - endothelial cell, BM - basement membrane, E – erythrocyte, m – mitochondrion, A – axon, N – neuron,
P – pericyte, PM – perivascular macrophage, Nu – nucleus, V – vacuole, . - extracellular edematous space. Magnifications: (A) 7,100x; (C), (D):
4,400x; (B): 28,000x; (E): 11,000x.
doi:10.1371/journal.pone.0016601.g004
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endothelial cells and pericytes in MPS III B mice as determined
via electron microscopy might severely compromise BBB.
Another of our findings was that perivascular macrophages in
close contact with capillary basement membrane were highly
vacuolated. Large vacuoles fully covered the cell cytoplasm similar
to microglial cells with great inclusions [12]. However, perivascu-
lar macrophages are cells with many properties distinct from
pericytes, microglia, and macrophages even though sharing similar
morphological appearance as blood-derived macrophages [28]
and importantly maintain O ` perivascular spaces as drainage
pathways for soluble and insoluble material from the brainO ´
[29]. Also, perivascular macrophages play an essential role during
CNS inflammation by facilitating the influx of leukocytes through
the BBB [30]. Future studies are needed to investigate inflamma-
tory processes in relation to BBB alterations in MPS III B mice.
It is our belief that the primary insult to BBB integrity is likely
from accumulated storage products within cellular components of
the BBB. Our data show accumulation of GM3 ganglioside, a
secondary storage product, not only in neurons and glial cells at
different stages of disease, but also in brain endothelium of MPS
III B mice at early disease stage, making it the most likely effector
damaging endothelial cells. Importantly, more GM3 accumulation
was seen in the endothelia of numerous brain blood vessels as
disease progressed.
Thus, endothelial and perivascular (pericytes and perivascular
macrophages) cell damage, detected in a majority of blood vessels
in different brain structures of MPS III B mice at early (3 months
of age) and late (6 months of age) stages of disease, compromised
BBB integrity and led to vascular leakage. However, it is possible
that BBB dysfunction occurred prior to or concurrent with the
appearance of neuropathological changes (1 month-old Naglu
mice). Also, observed differences in the degree of vascular leakage
for EB and albumin from different brain structures of MPS III B
mice will lead us to investigate functional vascular pathology in
younger mice. Surprisingly, more capillary leakage was seen in
some brain structures (i.e. hippocampus) of early symptomatic
mice (3 months of age) or similar (i.e. cerebral cortex [M2] and
cerebellar lobules [6–9Cb]) than late symptomatic animals (6 and
10–12 months of age) (see Table 1). Currently, no definitive
explanation can be made for this differential leakiness. One of our
speculations is that the observed brain regions differ in metabolic
functional activity, especially in growing animals, and higher
activity may require more substantial exchanges of nutrition and
metabolites. If the BBB is already weakened in these brain areas,
more vascular leakage might occur. Quantitative analysis of dye
extravasation will be necessary to further investigate differential
leakage and is planned for our future studies. Collectively,
determining the evolution of BBB dysfunction in MPS III B is
important not only for understanding this additional aspect of
disease pathogenesis, but is also critical to the development of a
successful MPS IIIB therapy. Since our study is ongoing, some
clarification regarding possible mechanism(s) of BBB impairment
is expected.
Special attention should be given to the possibilities for cerebral
hemorrhages in MPS III B. A microaneurysm adjacent to a
Figure 5. Evans Blue (EB) fluorescence in the brains of Naglu mice. In the brain, EB can be clearly detected within the blood vessels (A, B, C,
red, arrowheads) in the control C57 BL/6J mouse at 12 months of age. In Naglu mice, vascular leakage of EB (red, arrows) is visible in various brain
structures (D, E, F) at early (3 months of age), (J, H, I) at late (6 months of age), and (J, K, L) at end stage of disease (10 months of age). Significant EB
diffusion into the brain parenchyma from many blood vessels can be detected in end-stage Naglu mouse (10–12 months of age). Cx – cerebral
cortex, Hip – hippocampus, Crb – cerebellum. Scale bar in A through L is 25 mm.
doi:10.1371/journal.pone.0016601.g005
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late symptomatic mouse. Intracerebral hemorrhage is a serious
condition typically resulting from damage in the bleeding brain
area and is a common cause of stroke. This hemorrhage may have
been caused by weakened BBB competence, especially of some
structural components. Although this is the first microaneurysm
reported in MPS III B mice, awareness of the possibility for
microaneurysms in human MPS III B patients is important.
Together, our study results clearly demonstrate BBB impair-
ment in various brain structures in a mouse model of MPS III B
at different stages of disease. It is important to confirm this BBB
impairment as an additional mechanism of disease pathogenesis
in MPS III patients, an investigation which will be the focus of
our future study. The likelihood of severely damaged endothelial
and perivascular cells leading to breakdown of BBB integrity
should be considered in treatment development for MPS III B,
particularly in regards to drug delivery across the blood-brain
barrier. Restoration of BBB integrity is essential and should
benefit patients in numerous ways including re-establishing
neuroprotection.
Materials and Methods
Animals
All described procedures were approved by the Institutional
Animal Care and Use Committee at USF and conducted in
Table 1. Pattern of vascular leakage in the brains of Naglu mice at different stages of disease.
Naglu mice,
age Cx Hip Cb Md MB OB PS ST TH
EB/Alb EB/Alb EB/Alb EB/Alb EB/Alb EB/Alb EB/Alb EB/Alb EB/Alb
3m o ++/++ ++/++ ++/++ + /++ /-- --/-- +/-- +/++ /+
6m o ++/++ +/++ + /++ + /++ /+ --/-- +/++ /++ /+
10–12 mo ++/++ +/ ++ + /++ + /++ /+ --/ -- +/++ /++ /+
Key: Cx – cerebral cortex, Hip – hippocampus, Cb – cerebellum, Md – medulla, MB – midbrain, OB – olfactory bulb, PS – pons, ST – striatum, TH – thalamus, EB –
Evans Blue, Alb – albumin, -- - no leak, + - moderate leak (near abluminal side of the capillaries), ++ - significant leak (at a distance from the capillaries). Note: no vascular
leakage was determined in examined brain blood vessels from control mice at 3, 6 or 10–12 months of age.
doi:10.1371/journal.pone.0016601.t001
Figure 6. Immunohistochemical staining of albumin in the brains of Naglu mice. Albumin immunostaining can clearly be seen within the
blood vessels (A, B, C, green, arrowheads) of control C57 BL/6J mouse at 12 months of age. In Naglu mice, albumin extravasation (green, arrows) can
be seen in various brain structures (D, E, F) at early (3 months of age), (G, H, I) at late (6 months of age), and (J, K, L) end stages of disease (10
months of age). Cx – cerebral cortex, Hip – hippocampus, Crb – cerebellum. Scale bar in A through L is 25 mm.
doi:10.1371/journal.pone.0016601.g006
BBB in MPS III B
PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e16601compliance with the Guide for the Care and Use of Laboratory Animals.
All animals used in the study were obtained from our established
colony of Naglu mice developed from heterozygous breeding pairs
(The Jackson Laboratory, Bar Harbor, Maine). Further develop-
ment of the knockout strain continued on the background strain
C57BL/6J. Heterozygous breeding pairs were used to produce
littermates of three phenotypes: homozygote, heterozygote, and
wild-type. Genotyping of animals was performed by B6.129S6-
Naglu
tm1Efn probe hybridization assay via manufacture’s protocol
(Transnetyx, Inc., Cordova, TN) of tail biopsy (10 mg of tissue) at
10–15 days of age. Thirty three mice were used: 8 early
symptomatic (4 males, 4 females, 3 months of age, homozygotes),
8 late symptomatic (4 males, 4 females, 6 months of age,
homozygotes), 4 end stage (2 males, 2 females, 10–12 months of
age, homozygotes), and 13 wild type C57BL/6J mice of the same
ages (1 male, 1 female, 3 months of age; 2 males, 1 female, 6
months of age; 5 males, 3 females, 10–12 months of age).
Microvessel ultrastructure in various brain regions (cerebral
cortex, hippocampus, cerebellum, and striatum) from mutant
mice at early or late stage disease and wild type mice was
examined with an electron microscope (EM). Functional integrity
of the BBB was determined by Evans blue dye and albumin
leakage via immunohistochemistry.
Evans Blue dye
Evans Blue dye (EB, Aldrich Chemical), 961 Da, was used as a
tracer for assessing BBB disruption. Naglu (n=2 of each sex per
group: 3, 6, 10–12 months of age) and wild type (n=2 of each sex,
10–12 months of age) mice were intravenously injected with 2%
EB in saline solution via the jugular vein 30–40 min prior to
euthanasia. The surgical procedure was performed as we
previously described [19]. Briefly, mice were anesthetized with
Isoflurane, delivered using a calibrated vaporizer equipped
induction chamber and nose cone and administered at 2–5% in
O2 (2 L/min) to induce anesthesia and then decreased to 2% to
maintain anesthesia. The jugular vein was exposed and isolated
using blunt dissection. The vein was ligated and a 31-gauge
needle, attached to a 100-ml Hamilton syringe was placed into the
lumen of the vein and sutured in place. Evans Blue was delivered
(0.2 ml/100g, 40 ml/mouse) during 2 min. The needle was
withdrawn, the suture tightened, and the incision closed with
Vetbond.
Euthanasia and tissue preparation
Euthanasia of all mice was achieved under deep pentobarbital
(150 mg/kg) anesthesia. Perfusion was not performed, avoiding
any mechanical disruption or collapse of blood capillaries and
allowing determination of BBB condition without external
manipulations for delivery washing/fixative solutions similarly to
our previously published studies [19,20]. Additionally, using non-
perfused mice allowed observations of administered EB dye and
albumin within or outside blood vessels depending upon BBB
condition. Mice receiving an EB injection were euthanized 30–
40 min after injection. Brains were immediately removed, fixed
intact in 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer
(PB), pH 7.2, for 24 hrs and then cryoprotected in 20% sucrose in
0.1 M PB (pH 7.2) overnight. Sagittal brain sections were cut at
30 mm in a cryostat and used for immunohistochemical analysis of
EB leakage. Mice assayed for EM analysis were also euthanized as
described above. Their brains were immediately removed and
Figure 7. Immunohistochemical staining for GM3 ganglioside in the brains of Naglu mice. In the brain of control C57 BL/6J mouse at 12
months of age, GM3 ganglioside is not detected within the vascular endothelium of blood vessels (A, B, C, arrowheads). In early symptomatic (3
month of age) Naglu mice, some endothelial cells stained positive for GM3 (D, E, F, arrows) and some cells were negative for GM3 (D, E, F,
arrowheads). GM3 accumulation (arrows) was seen in the endothelia of numerous brain blood vessels (G, H, I) at late (6 months of age) and (J, K, L)
at end stages of disease (10 months of age). Significant GM3 ganglioside accumulation was also seen in neurons (asterisks) in Naglu mice. Cx –
cerebral cortex, Hip – hippocampus, Crb – cerebellum. Scale bar in A through I is 25 mm.
doi:10.1371/journal.pone.0016601.g007
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The next day, brains were cut into 1 mm slices, mapped against a
diagram of the whole slice, and regions to be studied were
removed from the slices and fixed overnight in 2.5% glutaralde-
hyde in 0.1 M PB (Electron Microscopy Sciences, Inc., Hatfield,
PA) at 4uC. The following day, tissues were transferred to a fresh
change of the above buffer and stored for further EM processing.
Electron microscopy
The BBB structural characteristics were identified in different
brain structures of Naglu mutant male and female mice at 3 and 6
months of age and compared to wild type control mice (10–12
months old) using electron microscopy. Structural integrity of
microvessels [20] was analyzed in the cortex (M2), hippocampus
(dentate gyrus), striatum (caudate putamen), and cerebellum (6–
9 Cb) of the brain. Briefly, tissue samples were post-fixed in 1%
osmium tetroxide (Electron Microscopy Sciences, Inc., Hatfield,
PA) in 0.1 M PB for 1 hour at room temperature (RT). Following
osmication, the tissues were dehydrated at RT in a graded series of
acetone dilutions (30%, 50%, 70%, and 95% acetone in water), 15
minutes each change. Three 15-minute changes in 100% acetone
were then made and the tissues were transferred to a 50:50 mix of
acetone and LX112 epoxy resin embedding mix (Ladd Research
Industries, Burlington VT). The tissues were infiltrated with this
mix for 1 hour under vacuum. The tissues were then transferred to
a 100% LX112 embedding mix and infiltrated for 1 hour on a
rotator. Two more 1-hour infiltration steps were performed with
fresh changes of the embedding mix. The tissues were further
infiltrated overnight in fresh embedding medium at 4uC. On the
following day, the tissues were infiltrated in two additional changes
of embedding medium at RT, 4 hours per change, and then
embedded in a fresh change of resin in tissue capsules. The blocks
were polymerized at 70uC in an oven overnight. The blocks were
trimmed and then sectioned with a diamond knife on an LKB
Huxley ultramicrotome. Thick sections cut at 0.35 mm were
placed on glass slides and stained with 1% toluidine blue stain.
Thin sections were cut at 80–90 nm, placed on copper grids, and
stained with uranyl acetate and lead citrate.
Detection of BBB condition
For analysis of BBB ultrastructure, brain structures (cerebral
cortex, hippocampus, cerebellum, and striatum) were examined
and photographed with a FEI Morgagni transmission electron
microscope (FEI, Inc., Hillsboro, OR), using an Olympus
MegaView III digital camera (ResAlta Research Technologies
Corp., Golden, CO.) at 60 kV. For identification of EB, serial
tissue sections of the brain were thaw-mounted on slides, washed
with deionized water to remove the freezing medium, and then
rinsed several times in phosphate-buffered saline (PBS). The slides
were coverslipped with Vectashield (Vector Laboratories) and
examined under an Olympus BX60 epifluorescence microscope
by an assistant blinded to mouse genotype and age.
Immunohistochemistry
Immunohistochemical staining for mouse albumin was per-
formed to determine vascular integrity in the brain. Brain tissues
were blocked for 60 min prior to applying goat anti-mouse serum
albumin antibody conjugated to FITC (1:300, Alpha Diagnostic
International). Tissue sections were then incubated for 2 hrs at
RT. The brain tissues were rinsed three times in PBS and then
coverslipped with Vectashield (Vector Laboratories). Immunohis-
tochemical staining for GM3 ganglioside was performed to detect
this secondary storage product in the brains of Naglu mice as
previously described [10]. Serial tissue sections of mutant and
control mouse brains were rinsed several times in PBS to remove
the freezing medium. The brain tissues were then incubated in a
blocking solution of 10% normal goat serum (NGS) and 0.3%
Triton X-100 in PBS for 60 min at RT. Mouse monoclonal
antibody GM3 (1:100, NeuAc, Cosmo Bio Co., LTD, Tokyo,
Japan) with 1.5% NGS, and 0.3% Triton X-100 in PBS was
applied on the slides overnight at 4uC. The slides were rinsed in
PBS and incubated with biotin-labeled goat-anti-mouse secondary
antibody (1:200, Vector) for 60 min at RT followed by an avidin-
biotin-peroxidase (ABC-Elite kit, Vector) with 3,3-diaminobenzi-
dine (DAB, Vector). The sections were examined using an
Olympus BX60 microscope.
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